Image source: The Motley Fool.
Coherus BioSciences Inc (NASDAQ: CHRS)
Q1 2021 Earnings Call
May 6, 2021 , 4:30 p.m. ET
Operator
For further details see:
Coherus BioSciences Inc (CHRS) Q1 2021 Earnings Call TranscriptImage source: The Motley Fool.
Coherus BioSciences Inc (NASDAQ: CHRS)
Q1 2021 Earnings Call
May 6, 2021 , 4:30 p.m. ET
Operator
For further details see:
Coherus BioSciences Inc (CHRS) Q1 2021 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
– In preclinical studies, CHS-1000 shows a high affinity for human ILT4, reverses ILT4-mediated immunosuppressive functions, leading to activati...
– In preclinical studies, CHS-1000 shows a high affinity for human ILT4, reverses ILT4-mediated immunosuppressive functions, leading to activation of immune cells and increased cytokine secretion – – Mechanism may enhance antitumor responses with immunothera...
2024-03-14 18:28:43 ET The final set of results for Coherus Biosciences ' (NASDAQ: CHRS) 2023 was released after market hours on Wednesday, and investors reacted with displeasure the following day. They traded the stock down by more than 6% Thursday, a much steeper fall than the 0.6...